World's Best Scientists 2026 revealed!
Michaela Fontenay

Michaela Fontenay

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
21700
World Ranking
13528
National Ranking
512

Overview

Michaela Fontenay is affiliated with the Institut Cochin in France and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their scientific work primarily focuses on hematology, molecular biology, genetics, immunology, and infectious diseases, with a significant number of publications addressing various aspects of blood-related disorders and immune system function.

The scientist has published work in several frequent venues including:

  • Blood
  • Leukemia Research
  • Cytometry Part B Clinical Cytometry
  • HemaSphere
  • Leukemia

Co-authorship patterns reveal frequent collaborations with the following researchers:

  • Olivier Kosmider (45 publications)
  • Nicolas Chapuis (37 publications)
  • Pierre Fenaux (27 publications)
  • Matteo Giovanni Della Porta (20 publications)
  • Joop H. Jansen (19 publications)

Their main research themes cover acute myeloid leukemia, myeloproliferative neoplasms, COVID-19 clinical research, epigenetics and DNA methylation, cancer genomics and diagnostics, as well as the short- and long-term healthcare impacts of COVID-19.

Significant recent papers authored or co-authored by Michaela Fontenay include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022, Leukemia
  • Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19, 2020, Cell
  • Molecular International Prognostic Scoring System for Myelodysplastic Syndromes, 2022, NEJM Evidence
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes, 2020, Nature Medicine
  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS, 2020, Blood

The research of Michaela Fontenay spans highly specialized topics within hematology and molecular biology, highlighting contributions to disease classification systems, prognostic scoring in myelodysplastic syndromes, and investigations into immune responses related to COVID-19 severity.

Best Publications

  • Mutation in TET2 in Myeloid Cancers

    François Delhommeau;Sabrina Dupont;Véronique Della Valle;Chloé James

  • TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

    Cyril Quivoron;Cyril Quivoron;Cyril Quivoron;Lucile Couronné;Lucile Couronné;Lucile Couronné;Véronique Della Valle;Véronique Della Valle;Véronique Della Valle;Cécile K. Lopez;Cécile K. Lopez;Cécile K. Lopez

  • Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.

    Aymeric Silvin;Nicolas Chapuis;Garett Dunsmore;Anne-Gaëlle Goubet

  • Heat shock proteins: essential proteins for apoptosis regulation

    D Lanneau;M E Brunet;M E Brunet;E Frisan;É Solary;É Solary

  • Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

    R Itzykson;O Kosmider;T Cluzeau;V Mansat-De Mas

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

    Olivier Kosmider;Véronique Gelsi-Boyer;Meyling Cheok;Sophie Grabar

  • Vital functions for lethal caspases

    Sophie Launay;Olivier Hermine;Michaëla Fontenay;Guido Kroemer

  • Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

    Frederik Damm;Olivier Kosmider;Véronique Gelsi-Boyer;Véronique Gelsi-Boyer;Aline Renneville

  • Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

    O Kosmider;V Gelsi-Boyer;L Slama;F Dreyfus

  • TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

    Olivier Kosmider;Véronique Gelsi-Boyer;Marion Ciudad;Cindy Racoeur

  • Clonal architecture of chronic myelomonocytic leukemias.

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Aline Renneville;Margot Morabito;Margot Morabito

  • Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.

    Dorothée Selimoglu-Buet;Orianne Wagner-Ballon;Véronique Saada;Valérie Bardet

  • Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

    Thorsten Braun;Raphael Itzykson;Aline Renneville;Benoit de Renzis

  • TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    Detlef Haase;Kristen E Stevenson;Donna Neuberg;Jaroslaw P Maciejewski

  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    Luca Malcovati;Kristen Stevenson;Elli Papaemmanuil;Donna Neuberg

  • BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

    Frederik Damm;Frederik Damm;Virginie Chesnais;Yasunobu Nagata;Kenichi Yoshida

  • NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity

    Florence Armstrong;Florence Armstrong;Philippe Brunet de la Grange;Philippe Brunet de la Grange;Bastien Gerby;Bastien Gerby;Marie-Christine Rouyez;Marie-Christine Rouyez

  • Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

    Olivier Nibourel;Olivier Kosmider;Meyling Cheok;Nicolas Boissel

Frequent Co-Authors

Eric Solary
Eric Solary Institut Gustave Roussy
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Olivier Bernard
Olivier Bernard University of Paris-Saclay
Nathalie Droin
Nathalie Droin Institut Gustave Roussy
Claude Preudhomme
Claude Preudhomme University of Lille
Aline Renneville
Aline Renneville Institut Gustave Roussy
William Vainchenker
William Vainchenker Institut Gustave Roussy
Carmen Garrido
Carmen Garrido University of Burgundy
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens pathways to a wide range of online degrees and rewarding careers. Many students choose to complement their science background with advanced business skills by pursuing the cheapest online MBA healthcare management options. These programs equip graduates to step into leadership roles in hospitals, labs, and biotech firms.

For those interested in health informatics, earning a certification as a certified coding specialist can provide a fast track into the booming field of medical coding. These professionals play a critical role in translating complex biological and medical information into universal codes for healthcare records and billing.

If you're considering this route, it's helpful to research medical coding jobs salary prospects. Many positions offer competitive pay and flexible remote work opportunities. Still uncertain? Explore whether is medical coding a good career to determine if this pathway aligns with your interests and goals.

Best Scientists Citing Michaela Fontenay

Trending Scientists